Sensient Technologies Corporation · NYSE:SXT
Sensient Technologies — Sidoti Fall Virtual Investor Conference 2022
15 slides from Sensient Technologies's conference presentation, Sep 21, 2022
Slide 1: Sidoti Investor Conference
Sidoti Investor Conference September 21, 2022
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This document contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors c
Slide 3: Non-GAAP Financial Measures
NON-GAAP FINANCIAL MEASURES Within this document, the Company reports certain non-GAAP financial measures, including: (1) adjusted revenue, adjusted operating income, and adjusted operating margin (which exclude divestiture & other related costs, the results of the divested product lines, and restru
Slide 4: Sensient Technologies Corporation
Sensient Technologies Corporation Provider of customized solutions for the food and beverage, pharmaceutical, and personal care markets Global market leader offering an extensive portfolio of flavor and color technology platforms and solutions Exceptional innovation & applications expertise with uni
Slide 5: Group Overview
Group Overview Flavors & Extracts Group 2021 Revenue: $739M 2021 Adj. Revenue*: $712M (+9.4% vs. 2020) Core Areas of Focus: Flavors & Extracts, Natural Ingredients, and Other Flavor Ingredients Color Group 2021 Revenue: $545M 2021 Adj. Revenue*: $543M (+9.4% vs. 2020) Core Areas of Focus: Food & Bev
Slide 6: Flavors & Extracts Capabilities
Flavors & Extracts Capabilities • Unique ability to service global, regional, and local customers • Broad product offering includes flavors, extracts, taste modulation, and natural ingredients (onion, garlic, capsicums) • Leading flavor masking technologies • Strong innovation and application capabi
Slide 7: Color Capabilities
Color Capabilities • Leader in natural color technologies that improve product performance and stability • Strong innovation and applications expertise • Extensive range of extraction technologies and expanding agronomy capabilities • Pharmaceutical business provides unique solutions with colors, fl
Slide 8: Financial Performance
Financial Performance DOLLARS IN MILLIONS DOLLARS IN MILLIONS DOLLARS IN MILLIONS DOLLARS IN MILLIONS * Adjusted operating income and adjusted operating margin are Non-GAAP metrics. Please see our 8 GAAP to Non-GAAP Reconciliation at the end of this document.
Slide 9: Capital Allocation
Capital Allocation $250 Prioritize ROI capital projects $200 $9 $31 Maintain financial flexibility to pursue $118 $56 $14 M&A DOLLARS IN MILLIONS $51 $150 $87 $61 Dividend payout increased 5.1% in $54 $100 $57 $52 2021 $39 $67 $50 $87 Excess capital returned to $77 $66 $62 $43 shareholders through o
Slide 10: Why Invest?
Why Invest? Strong competitive position ‘Sticky’ business (& low portion of customer costs) Global presence Exposure to stable and growing markets Focused on improving returns and on growth 10
Slide 11: Appendix
APPENDIX *Amounts in thousands, except percentages
Slide 12: Non-GAAP Financial Measures
Non-GAAP Financial Measures Year Ended December 31, 2021 Foreign Adjusted Exchange Local Revenue Total Rates Adjustments* Currency Flavors & Extracts (0.4%) 1.6% (11.4%) 9.4% Color 8.8% 2.1% (2.7%) 9.4% Asia Pacific 11.6% 1.7% (0.2%) 10.1% Total Revenue 3.6% 1.8% (7.3%) 9.1% *Revenue adjustments con
Slide 13: Non-GAAP Financial Measures (Cont'd)
Non-GAAP Financial Measures (Cont’d) Year Ended December 31, 2021 2020 2019 Revenue (GAAP) $ 1,380,264 $ 1,332,001 $ 1,322,934 Revenue of the divested product lines (30,062) (113,553) (143,172) Adjusted revenue $ 1,350,202 $ 1,218,448 $ 1,179,762 Operating income (GAAP) $ 170,028 $ 152,656 $ 121,110
Slide 14: Non-GAAP Financial Measures (Cont'd)
Non-GAAP Financial Measures (Cont’d) Results by Segment Year Ended December 31, Adjusted Adjusted Adjusted Revenue 2021 Adjustments* 2021 2020 Adjustments* 2020 2019 Adjustments* 2019 Flavors & Extracts $ 739,427 $ (27,837) $ 711,590 $ 742,035 $ (99,543) $ 642,492 $ 700,356 $ (107,363) $ 592,993 Col
Slide 15: Sensient
am SENSIENT —eomnv SENSIENT: 8
Sensient Technologies — Sidoti Fall Virtual Investor Conference 2022 on 6ix